Metastatic medulloblastoma in an adult; treatment with temozolomide

Acta Neurologica Belgica

Volumn 107, Issue 2, 2007, Pages 51-54

  Poelen, J ^a   Bernsen, H J J A ^a   Prick, M J J ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Adult; Medulloblastoma; Recurrences; Temozolomide; Treatment

Indexed keywords

CYTARABINE; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN DISEASE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DEATH; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; NERVE DEGENERATION; NERVE FIBER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSTOPERATIVE CARE; RADIATION DOSE; SPINAL CORD METASTASIS; UNSPECIFIED SIDE EFFECT;

EID: 34447535420     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. BRANDES A.A., PALMISANO V., MONFARDINI S. Medulloblastoma in adults: Clinical characteristics and treatment. Cancer treatment reviews, 1999, 25(1): 3-12.
2. BRANDES A. A., PARIS M. K. Review of the prognostic factors in medulloblastoma of children and adults. Critical Reviews in Oncology/ Hematology, 2004, 50: 121-128.
3. FRIEDMANN H.S., DOLAN M. E., PEGG A. E., MARCELLi S., KEIR S. et al. Activity of temozolomide in the treatment of central nervous system tumour xenografts. Cancer Research, 1995, 55 (13): 2853-7.
4. HAZUKA M. B., DEBOISE D. A., HENDERSON R. H., KINZIE J. J.: Survival results in adult patients treated for medulloblastoma. Cancer, 1992, 15: 69 (8): 2143-2148.
5. HERRLINGER U., STEMRECHER A., RIEGER J., HAU P., KORTMANN R. D. et al. Adult medulloblastoma. Prognostic factors and response to therapy at diagnosis and at relapse. J. Neurol., 2005, 252: 291-299.
6. HONGENG S., VISUDTIBHAN A., DHANACHAI M., LAOTHAMATUS J., CHIAMCHANYA S. Treatment of leptomeningeal relapse of medulloblastoma with temozolomide. Journal of pediatric haematology/oncology, 2002, 24 (7): 591-593.
7. RAO R., ROBINS H., MEHTA M. Late recurrence of a primitive neuro-ectodermal tumour. Oncology, 2001, 61: 189-191.
8. STUPP R., MASON W. P., VAN DEN BENT M. J., WELLER M., FISHER B. et al. Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. The new England Journal of Medicine, 2005, 352: 987-96.
9. TABORI U., SUNG L., HUKIN J., LAPERRIERE N., CROOKS B. et al. Distinctive clinical course and pattern of relapse in adolescents with a medulloblastoma. Int. J. Radiation Oncology Biol. Phys., 2005, 20 (10) 1-6.
10. ZIA M. I., FORSYTH P., CHAUDHRY A., RUSSELL J., STEWART D. A. Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma. Bone Marrow Transplantation, 2002, 30: 565-569.